In clear cell renal cell carcinoma, the DHODH inhibitor selectively inhibited tumor growth in GPX4-low tumors, while combined treatment with sulfasalazine, which also induces ferroptosis, synergistically inhibited the growth of GPX4-high tumors[94]. Here, GPX4 is linked to clear cell renal carcinoma.